{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"37","upperLimit":"69","value":"54"},{"groupId":"OG001","lowerLimit":"40","upperLimit":"70","value":"55"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"47"}],"units":"Participants"}],"description":"For Cohorts A and C: Objective Response Rate (ORR) is defined as the percentage of patients achieving a complete response (CR) or partial response (PR) based on RECIST 1.1 criteria. CR = disappearance of all target lesions, PR is =\\>30% decrease in sum of diameters of target lesions.","dispersionType":"95% Confidence Interval","groups":[{"description":"MK-3475: MK-3475 10 mg/kg every 14 days","id":"OG000","title":"Cohort A: MSI Positive Colorectal Cancer"},{"description":"MK-3475: MK-3475 10 mg/kg every 14 days","id":"OG001","title":"Cohort C: MSI Positive Non-Colorectal Cancer"}],"paramType":"NUMBER","populationDescription":"It was a pre-specified objective to complete this objective in Cohort A and C only.","reportingStatus":"POSTED","timeFrame":"28 months","title":"Objective Response Rate in MSI Positive Solid Tumor Malignancies Using Response Evaluation Criteria in Solid Tumors (RECIST 1.1)","type":"PRIMARY","unitOfMeasure":"percentage of participants"}